How is HIV-associated distal painful sensorimotor polyneuropathy diagnosed?

1. Cornblath DR, McArthur JC. Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex. Neurology. 1988 May. 38(5):794-6. [Medline].

2. de Gans J, Portegies P. Neurological complications of infection with human immunodeficiency virus type 1. A review of literature and 241 cases. Clin Neurol Neurosurg. 1989. 91(3):199-219. [Medline].

3. Ferrari S, Vento S, Monaco S, et al. Human immunodeficiency virus-associated peripheral neuropathies. Mayo Clin Proc. 2006 Feb. 81(2):213-9. [Medline].

4. Adem KS, Janakiraman B, Gebremeskel BF, Chala MB, Gelaw AY, Alemu K. Epidemiology and factors associated with peripheral neuropathy among HIV infected patients in Gondar, Ethiopia: A cross-sectional study. PLoS One. 2019. 14 (1):e0211354. [Medline]. [Full Text].

5. Aziz-Donnelly A, Harrison TB. Update of HIV-Associated Sensory Neuropathies. Curr Treat Options Neurol. 2017 Aug 31. 19 (10):36. [Medline].

6. Prior DE, Song N, Cohen JA. Neuromuscular diseases associated with Human Immunodeficiency Virus infection. J Neurol Sci. 2018 Apr 15. 387:27-36. [Medline].

7. Kaku M, Simpson DM. Neuromuscular complications of HIV infection. Handb Clin Neurol. 2018. 152:201-212. [Medline].

8. Kokotis P, Schmelz M, Papadimas GK, et al. Polyneuropathy induced by HIV disease and antiretroviral therapy. Clin Neurophysiol. 2013 Jan. 124(1):176-82. [Medline].

9. Centner CM, Bateman KJ, Heckmann JM. Manifestations of HIV infection in the peripheral nervous system. Lancet Neurol. 2013 Mar. 12(3):295-309. [Medline].

10. Hao S. The Molecular and Pharmacological Mechanisms of HIV-Related Neuropathic Pain. Curr Neuropharmacol. 2013 Sep. 11 (5):499-512. [Medline].

11. Cooley TP, Kunches LM, Saunders CA, Ritter JK, Perkins CJ, McLaren C, et al. Once-daily administration of 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Results of a Phase I trial. N Engl J Med. 1990 May 10. 322 (19):1340-5. [Medline].

12. Wright E, Brew B, Arayawichanont A, Robertson K, Samintharapanya K, et al. Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region. Neurology. 2008 Jul 1. 71 (1):50-6. [Medline].

13. Lewis W, Dalakas MC. Mitochondrial toxicity of antiviral drugs. Nat Med. 1995 May. 1 (5):417-22. [Medline].

14. Simpson DM, Kitch D, Evans SR, et al. HIV neuropathy natural history cohort study: assessment measures and risk factors. Neurology. 2006 Jun 13. 66(11):1679-87. [Medline].

15. Simpson DM, Olney RK. Peripheral neuropathies associated with human immunodeficiency virus infection. Neurol Clin. 1992 Aug. 10(3):685-711. [Medline].

16. Primary care of veterans with HIV. U.S. Department of Veterans Affairs. Available at https://www.hiv.va.gov/pdf/pcm-manual.pdf. 2019 Jan 01; Accessed: August 04, 2019.

17. Morgello S, Estanislao L, Simpson D, et al. HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV Brain Bank. Arch Neurol. 2004 Apr. 61(4):546-51. [Medline].

18. Cherry CL, Skolasky RL, Lal L, Creighton J, Hauer P, Raman SP, et al. Antiretroviral use and other risks for HIV-associated neuropathies in an international cohort. Neurology. 2006 Mar 28. 66 (6):867-73. [Medline].

19. Evans SR, Ellis RJ, Chen H, Yeh TM, Lee AJ, Schifitto G, et al. Peripheral neuropathy in HIV: prevalence and risk factors. AIDS. 2011 Apr 24. 25 (7):919-28. [Medline].

20. Anastasi JK, Capili B, McMahon DJ, Scully C. Acu/Moxa for distal sensory peripheral neuropathy in HIV: a randomized control pilot study. J Assoc Nurses AIDS Care. 2013 May-Jun. 24 (3):268-75. [Medline].

21. Chen H, Clifford DB, Deng L, Wu K, Lee AJ, Bosch RJ, et al. Peripheral neuropathy in ART-experienced patients: prevalence and risk factors. J Neurovirol. 2013 Dec. 19 (6):557-64. [Medline].

22. Holzinger ER, Hulgan T, Ellis RJ, Samuels DC, Ritchie MD, et al. Mitochondrial DNA variation and HIV-associated sensory neuropathy in CHARTER. J Neurovirol. 2012 Dec. 18 (6):511-20. [Medline].

23. Robinson-Papp J, Gelman BB, Grant I, Singer E, Gensler G, Morgello S, et al. Substance abuse increases the risk of neuropathy in an HIV-infected cohort. Muscle Nerve. 2012 Apr. 45 (4):471-6. [Medline].

24. Cornblath DR, Hoke A. Recent advances in HIV neuropathy. Curr Opin Neurol. 2006. 5:446-50. [Medline].

25. Robinson-Papp J, Sharma S, Simpson DM, Morgello S. Autonomic dysfunction is common in HIV and associated with distal symmetric polyneuropathy. J Neurovirol. 2013 Apr. 19 (2):172-80. [Medline].

26. Hart AM, Wilson AD, Montovani C, et al. Acetyl-l-carnitine: a pathogenesis based treatment for HIV-associated antiretroviral toxic neuropathy. AIDS. 2004 Jul 23. 18(11):1549-60. [Medline].

27. Hahn K, Arendt G, Braun JS, et al. A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies. J Neurol. 2004 Oct. 251(10):1260-6. [Medline].

28. Simpson DM, McArthur JC, Olney R, et al. Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial. Neurology. 2003 May 13. 60(9):1508-14. [Medline].

29. Simpson DM, Schifitto G, Clifford DB, et al. Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial. Neurology. 2010 Feb 2. 74(5):413-20. [Medline]. [Full Text].

30. Shlay JC, Chaloner K, Max MB, et al. Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS. JAMA. 1998 Nov 11. 280(18):1590-5. [Medline].

31. Simpson DM, Brown S, Tobias J. Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy. Neurology. 2008 Jun 10. 70(24):2305-13. [Medline].

32. Simpson DM, Brown S, Tobias JK, Vanhove GF. NGX-4010, a Capsaicin 8% Dermal Patch, for the Treatment of Painful HIV-associated Distal Sensory Polyneuropathy: Results of a 52-Week Open-Label Study. Clin J Pain. 2013 Feb 26. [Medline].

33. Mou J, Paillard F, Turnbull B, Trudeau J, Stoker M, Katz NP. Qutenza (capsaicin) 8% patch onset and duration of response and effects of multiple treatments in neuropathic pain patients. Clin J Pain. 2014 Apr. 30 (4):286-94. [Medline].

34. Estanislao L, Carter K, McArthur J, et al. A randomized controlled trial of 5% lidocaine gel for HIV-associated distal symmetric polyneuropathy. J Acquir Immune Defic Syndr. 2004 Dec 15. 37(5):1584-6. [Medline].

35. Ellis RJ, Toperoff W, Vaida F, et al. Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial. Neuropsychopharmacology. 2009 Feb. 34(3):672-80. [Medline].

36. Dorfman D, George MC, Schnur J, Simpson DM, Davidson G, Montgomery G. Hypnosis for Treatment of HIV Neuropathic Pain: A Preliminary Report. Pain Med. 2013 Jul. 14(7):1048-56. [Medline].

37. Sandoval R, Runft B, Roddey T. Pilot study: does lower extremity night splinting assist in the management of painful peripheral neuropathy in the HIV/AIDS population?. J Int Assoc Physicians AIDS Care (Chic). 2010 Nov-Dec. 9 (6):368-81. [Medline].

38. Sandoval R, Roddey T, Giordano TP, Mitchell K, Kelley C. Randomized Trial of Lower Extremity Splinting to Manage Neuropathic Pain and Sleep Disturbances in People Living with HIV/AIDS. J Int Assoc Provid AIDS Care. 2013 Dec 30. [Medline].

39. Geraci AP, Simpson DM. Neurological manifestations of HIV-1 infection in the HAART era. Compr Ther. 2001 Fall. 27 (3):232-41. [Medline].

40. Maschke M, Kastrup O, Esser S, et al. Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART). J Neurol Neurosurg Psychiatry. 2000 Sep. 69(3):376-80. [Medline].

41. Watters MR, Poff PW, Shiramizu BT, et al. Symptomatic distal sensory polyneuropathy in HIV after age 50. Neurology. 2004 Apr 27. 62(8):1378-83. [Medline].

42. Peters RP, Van Ramshorst MS, Struthers HE, McIntyre JA. Clinical assessment of peripheral neuropathy in HIV-infected children on antiretroviral therapy in rural South Africa. Eur J Pediatr. 2014 Sep. 173 (9):1245-8. [Medline].

43. Childs EA, Lyles RH, Selnes OA, Chen B, Miller EN, Cohen BA, et al. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology. 1999 Feb. 52 (3):607-13. [Medline].

44. Kume K, Ikeda K, Kamada M, Touge T, Deguchi K, Masaki T. [Successful treatment of HIV-associated chronic inflammatory demyelinating polyneuropathy by early initiation of highly active anti-retroviral therapy]. Rinsho Shinkeigaku. 2013. 53(5):362-6. [Medline].

45. Robinson-Papp J, Simpson DM. Neuromuscular diseases associated with HIV-1 infection. Muscle Nerve. 2009 Dec. 40(6):1043-53. [Medline].

46. Wang SX, Ho EL, Grill M, Lee E, Peterson J, Robertson K, et al. Peripheral neuropathy in primary HIV infection associates with systemic and central nervous system immune activation. J Acquir Immune Defic Syndr. 2014 Jul 1. 66 (3):303-10. [Medline].

Florian P Thomas, MD, PhD, MA, MS Chair, Neuroscience Institute and Department of Neurology, Director, National MS Society Multiple Sclerosis Center and Hereditary Neuropathy Foundation Center of Excellence, Hackensack University Medical Center; Founding Chair and Professor, Department of Neurology, Hackensack Meridian School of Medicine at Seton Hall University; Professor Emeritus, Department of Neurology, St Louis University School of Medicine; Editor-in-Chief, Journal of Spinal Cord Medicine

Florian P Thomas, MD, PhD, MA, MS is a member of the following medical societies: Academy of Spinal Cord Injury Professionals, American Academy of Neurology, American Neurological Association, Consortium of Multiple Sclerosis Centers, National Multiple Sclerosis Society, Sigma Xi

Disclosure: Nothing to disclose.

Erik Z Krause, DO Resident Physician, Department of Neurology, St Louis University School of Medicine

Erik Z Krause, DO is a member of the following medical societies: American Academy of Neurology, American Osteopathic Association

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Glenn Lopate, MD Associate Professor, Department of Neurology, Division of Neuromuscular Diseases, Washington University in St Louis School of Medicine; Consulting Staff, Department of Neurology, Barnes-Jewish Hospital

Glenn Lopate, MD is a member of the following medical societies: American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, Phi Beta Kappa

Disclosure: Nothing to disclose.

Niranjan N Singh, MBBS, MD, DM, FAHS, FAANEM Adjunct Associate Professor of Neurology, University of Missouri-Columbia School of Medicine; Medical Director of St Mary's Stroke Program, SSM Neurosciences Institute, SSM Health

Niranjan N Singh, MBBS, MD, DM, FAHS, FAANEM is a member of the following medical societies: American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, American Headache Society

Disclosure: Nothing to disclose.